Cointime

ChemoCentryx

company

About

ChemoCentryx is a biopharmaceutical company that develops medications for inflammatory and autoimmune diseases and cancer.

  • 101 - 250

Highlights

Total Funding Amount
$100M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$100M
Industries
Biotechnology,Health Care,Medical Device
Founded date
Jan 1, 1997
Number Of Employee
101 - 250
Operating Status
Active

ChemoCentryxis a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer.

ChemoCentryx focuses on the discovery, development, and commercialization of orally-administered small molecule therapeutics that target chemokine receptors and related chemo-attractant receptors.

The company's small molecule product candidates are designed to target a specific chemokine or chemo-attractant receptor, thereby blocking the inappropriate immune system cascade underlying a given disease.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$100M
ChemoCentryx has raised a total of $100M in funding over 2 rounds. Their latest funding was raised on Jan 9, 2020 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 9, 2020 Post-IPO Debt $100M 1 Hercules Capital — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
ChemoCentryx is funded by 1 investors. Hercules Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Hercules Capital Yes Post-IPO Debt
Cointime
เนื้อหา
บริษัท